Table 4.
Study | TP | FP | FN | TN | SEN (%) | SPE (%) | Note |
---|---|---|---|---|---|---|---|
Kumar et al. | 17 | 10 | 6 | 27 | 0.74 | 0.73 | PZ |
Aydin et al. | 34 | 17 | 82 | 77 | 0.29 | 0.82 | |
Koo et al. | 75 | 42 | 130 | 553 | 0.37 | 0.93 | b = 300 |
160 | 49 | 45 | 546 | 0.78 | 0.92 | b = 700 | |
174 | 38 | 31 | 557 | 0.85 | 0.94 | b = 1,000 | |
152 | 22 | 53 | 573 | 0.74 | 0.96 | b = 2,000 | |
Ibrahiem et al. | 57 | 10 | 11 | 14 | 0.84 | 0.58 | PZ |
Kim et al. | 158 | 49 | 22 | 443 | 0.88 | 0.9 | b = 1,000 |
128 | 40 | 52 | 452 | 0.71 | 0.92 | b = 2,000 | |
Yamamura et al. | 57 | 17 | 5 | 221 | 0.92 | 0.93 | |
Girometti et al. | 4 | 14 | 8 | 182 | 0.33 | 0.93 | |
Selnæs et al. | 23 | 10 | 8 | 114 | 0.74 | 0.92 | PZ |
Portalez et al. | 16 | 15 | 25 | 352 | 0.39 | 0.96 | PZ |
Tamada et al. | 39 | 11 | 64 | 286 | 0.38 | 0.96 | |
Rinaldi et al. | 42 | 0 | 6 | 9 | 0.88 | 1.0 | |
Yagci et al. | 58 | 34 | 11 | 155 | 0.84 | 0.82 | PZ |
Weidner et al. | 11 | 11 | 3 | 7 | 0.79 | 0.39 | PZ |
Kim et al. | 51 | 6 | 3 | 64 | 0.94 | 0.91 | PZ |
9 | 11 | 1 | 59 | 0.90 | 0.84 | TZ | |
Chen et al. | 42 | 37 | 9 | 164 | 0.82 | 0.82 | |
Iwazawa et al. | 150 | 114 | 34 | 414 | 0.82 | 0.78 | PZ |
88 | 109 | 46 | 469 | 0.66 | 0.81 | CZ | |
Miao et al. | 121 | 29 | 23 | 123 | 0.84 | 0.81 | |
Isebaert et al. | 359 | 44 | 617 | 732 | 0.37 | 0.94 | |
Vilanova et al. | 37 | 8 | 14 | 81 | 0.73 | 0.91 | |
Peng et al. | 49 | 6 | 12 | 37 | 0.8 | 0.86 | |
Lim et al. | 171 | 57 | 56 | 340 | 0.75 | 0.86 |
TP true positive, FP false positive, FN false negative, TN true negative, SEN sensitivity, SPE specificity, PZ peripheral zone, TZ transition zone, CZ central zone